查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1373203

荷尔蒙替代疗法市场 - 2018-2028 年全球产业规模、份额、趋势、竞争、机会和预测，按产品、给药途径、疾病类型、地区和竞争细分

Hormone Replacement Therapy Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Route of Administration, By Disease Type, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球荷尔蒙替代疗法 (HRT) 市场预计在 2024-2028 年预测期内将以高复合年增长率成长。在世界各个发展中国家的人们中常见的其他荷尔蒙失衡疾病的盛行率日益增加，预计将在预测期内为全球荷尔蒙替代疗法市场带来利润丰厚的成长。全球老年人口的成长以及某些荷尔蒙失调（例如男性更年期、甲状腺功能亢进、甲状腺功能减退症以及其他与老年人相关的疾病）预计将在预测期内推动全球荷尔蒙替代疗法市场的成长。此外，全球医疗保健基础设施的改善导致荷尔蒙替代疗法的创新，预计将在预测期内全球荷尔蒙替代疗法市场出现令人印象深刻的成长。

市场区隔

全球荷尔蒙替代疗法市场根据产品、给药途径、疾病类型、公司和地区进行细分。从产品来看，全球荷尔蒙替代疗法市场分为雌激素和黄体素替代疗法、HGH替代疗法、甲状腺激素替代疗法、睪固酮替代疗法和副甲状腺激素替代疗法。根据给药途径，全球荷尔蒙替代疗法市场分为口服、肠胃外、透皮等。根据疾病类型，市场分为更年期、甲状腺功能减退症、男性性腺功能减退症、生长激素缺乏症和副甲状腺功能减退症。

市场参与者

拜耳公司、辉瑞公司、默克公司、Viatris Inc.、诺和诺德公司、礼来公司、罗氏公司（基因泰克）、久光製药有限公司（ Noven Pharmaceuticals, Inc.)、ASCEND Therapeutics US, LLC。 （贝辛斯医疗保健）和艾伯维公司。

报告范围：

在本报告中，除了以下详细介绍的产业趋势外，全球荷尔蒙替代疗法市场还分为以下几类。

荷尔蒙替代疗法市场，分产品：

  • 雌激素和黄体酮替代疗法
  • HGH 替代疗法
  • 甲状腺激素替代疗法
  • 睾酮替代疗法
  • 副甲状腺素替代

荷尔蒙替代疗法市场（依给药途径）：

  • 口服
  • 注射用
  • 透皮
  • 其他的

荷尔蒙替代疗法市场，依疾病类型：

  • 停经
  • 甲状腺功能低下症
  • 男性性腺功能减退症
  • 生长激素缺乏
  • 副甲状腺功能减退症

全球荷尔蒙替代疗法市场，按地区：

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 亚太
  • 中国
  • 印度
  • 韩国
  • 澳洲
  • 日本
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 义大利
  • 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
  • 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

竞争格局

  • 公司简介：全球荷尔蒙替代疗法市场主要公司的详细分析

可用的客製化：

  • 根据给定的市场资料，TechSci Research 可根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球荷尔蒙替代疗法市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 副产品（雌激素和黄体酮替代疗法、HGH替代疗法、甲状腺激素替代疗法、睪固酮替代疗法和副甲状腺激素替代疗法）
    • 依给药途径（口服、肠胃外、透皮等）
    • 依疾病类型（更年期、甲状腺功能低下、男性性腺功能减退症、生长激素缺乏症和副甲状腺功能减退症）
    • 按地区
    • 按公司划分 (2022)
  • 产品市场地图

第 6 章：北美荷尔蒙替代疗法市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依给药途径
    • 依疾病类型
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲荷尔蒙替代疗法市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依给药途径
    • 依疾病类型
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区荷尔蒙替代疗法市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依给药途径
    • 依疾病类型
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第 9 章：南美洲荷尔蒙替代疗法市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依给药途径
    • 依疾病类型
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲荷尔蒙替代疗法市场展望

  • 市场规模及预测
    • 按价值和数量
  • 市占率及预测
    • 按产品分类
    • 依给药途径
    • 依疾病类型
    • 按国家/地区
  • MEA：国家分析
    • 南非荷尔蒙替代疗法
    • 沙乌地阿拉伯荷尔蒙替代疗法
    • 阿联酋荷尔蒙替代疗法

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

第 13 章：大环境分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 公司概况
  • 产品与服务
  • 财务（上市公司）
  • 最近的发展
  • SWOT分析
    • Bayer AG
    • Pfizer Inc.
    • Merck & Co., Inc.
    • TherapeuticsMD, Inc.
    • Novo Nordisk A/S
    • AbbVie Inc.
    • F. Hoffmann-La Roche Ltd. (Genentech)
    • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
    • ASCEND Therapeutics US, LLC. (Besins Healthcare)
    • Halozyme Therapeutics, Inc.

第 16 章：策略建议

第 17 章：关于我们与免责声明

简介目录
Product Code: 15746

Global hormone replacement therapy (HRT) market is expected to rise at a high CAGR during the forecast period, 2024-2028. Growing prevalence of other hormonal imbalance disorders which are common among people of various developing countries in the world are expected to register a lucrative growth to global hormone replacement therapy market in the forecast period. Growth in global geriatric population and certain hormonal disorders such as andropause, hyperthyroidism, hypothyroidism, and others which are associated with people during their elder age are expected to propel the growth of hormone replacement therapy market across the world in the forecast period. Furthermore, improvement in worldwide healthcare infrastructure which are leading to innovations in hormone replacement therapy are further expected to register an impressive growth to global hormone replacement therapy market in the forecast period.

Hormone Replacement Therapy (HRT) is a medical treatment that involves replacing the hormones that are produced in lower quantities in the body especially after treatment of certain types of cancer and menopause in women. Various types of hormone replacement therapy that are commonly performed across the world includes estrogen-only therapy, combination therapy, transdermal therapy, and bioidentical hormone therapy.

The United States of America, Canada, Australia, and several European countries such as France, Italy, and Sweden account for highest number of hormone replacement therapies performed among their population in the forecast period. Several health conditions that can be efficiently managed by hormone replacement therapy in the human body comprise of menopause symptoms, osteoporosis, hypogonadism, gender dysphoria, endometriosis, and breast cancer.

Rising Prevalence of Hormonal Imbalance Disorders

Hormonal imbalance disorders can be referred to development of certain health conditions which are caused by abnormality in the production, regulation, and function of hormones in the human body. Some of the hormonal imbalance disorders which can affect both men and women includes polycystic ovary syndrome (PCOS), thyroid disorders, adrenal disorders, pituitary gland disorders, reproductive disorders, parathyroid disorders, and others. Major risk factors which can lead to development of hormonal imbalances in a person include genetic predisposition, age, lifestyle choices, medical conditions, and environmental changes.

Among various hormonal disorders, polycystic ovary syndrome (PCOS) is one of the most prevalent hormonal disorders affecting women of reproductive age. It is estimated that PCOS affects 5-10% of women of reproductive age worldwide. South Asia, Middle East, and North Africa are some of the regions which account for highest number of PCOS cases in recent years. According to the report published by BMC on Reproductive Biology and Endocrinology in 2021, it has been observed that India stood at highest position for around 22.7% PCOS cases being diagnosed in the country, followed by 20% cases in Philippines, 15.9% cases in Australia, 13.7% cases in United Kingdom, 12.2% cases in United States of America, and so on.

Hormone Replacement Therapy involves taking synthetic hormones to replace the hormones that are not being produced adequately by the body. In case of polycystic ovary syndrome (PCOS), hormone replacement therapy is used to regulate menstrual cycles, reduce hair growth, and remove acne. Another common hormonal disorders which are prevailing people of every age group and gender worldwide are thyroid disorders such as hypothyroidism and hyperthyroidism. According to World Health Organization (WHO), around 750 million people are suffering from some form of thyroid disorder in the world. The prevalence of thyroid disorders increases with age which account for around 20% women over 60 years of age having some form of thyroid dysfunction. In some regions, such as Southeast Asia, Africa, and South America around 50% of people are diagnosed with iodine deficiency every year which leads to the development of goiter (enlarged thyroid gland) and hypothyroidism. Moreover, effective results in management of various hormonal disorders after hormone replacement therapy are expected to register an impressive growth of global hormone replacement therapy market in the forecast period.

Growth in Geriatric Population

With increase in age, people tend to develop more symptoms of various hormonal imbalance disorders in their body. Some of the most common hormonal imbalances which affect people during their elder age include menopause, hypothyroidism, andropause, adrenal insufficiency, and diabetes. Among various hormonal disorders, menopause accounts for highest number of instances across various developing countries of the world. According to Menopause Foundation of Canada, by 2025, more than 1 billion women in the world will be experiencing menopause. Various kind of symptoms which are experienced by people during menopause comprise of hot flushes, vaginal dryness, night sweats, weight gain, and others. According to the report published by Forth with Life in 2019, it has been observed that around 73% of people suffer from hot flushes during menopause followed by 63% of people suffering from drowsiness, 47% people from low concentration, 43% people from memory troubles, and so on. Moreover, growth in worldwide geriatric population and rise in certain hormonal imbalances which are associated with people during their elder age are further expected to register a lucrative growth to global hormone replacement therapy market in the forecast period. According to the report published by Population Reference Bureau (PRB) based on countries with the oldest populations in the world, it has been concluded that Japan is the foremost country in the world accounting for around 28.2% of geriatric people out of total population, followed by Italy with 22.8% of geriatric population, Greece, and Portugal with 21.8 %, and Germany with 21.4% of geriatric people out of the total population.

Development of Healthcare Infrastructure

Improvement in medical facilities provided by various hospitals and medical centers around the world is one of the significant factors which is expected to propel the growth of global hormone replacement therapy market in the forecast period. Moreover, establishment of various healthcare associations around the world along with availability of skilled healthcare professionals are allowing more people to undergo hormone replacement therapy in their individual countries which is thereby driving the growth of the market.

Market Segmentation

Global hormone replacement therapy market is segmented based on product, route of administration, disease type, company, and region. In terms of product, the global hormone replacement therapy market is categorized into estrogen and progesterone replacement therapy, HGH replacement therapy, thyroid hormone replacement therapy, testosterone replacement therapy, and parathyroid hormone replacement. Based on, route of administration, the global hormone replacement therapy market is segmented into oral, parenteral, transdermal, and others. Based on disease type, the market is segmented into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and hypoparathyroidism.

Market Players

Bayer AG, Pfizer Inc., Merck & Co., Inc., Viatris Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech), Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), ASCEND Therapeutics US, LLC. (Besins Healthcare), and AbbVie Inc.

Report Scope:

In this report, Global Hormone Replacement Therapy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below.

Hormone Replacement Therapy Market, By Product:

  • Estrogen and Progesterone Replacement Therapy
  • HGH replacement therapy
  • Thyroid hormone replacement therapy
  • Testosterone Replacement Therapy
  • Parathyroid Hormone replacement

Hormone Replacement Therapy Market, By Route of Administration:

  • Oral
  • Parenteral
  • Transdermal
  • Others

Hormone Replacement Therapy Market, By Disease Type:

  • Menopause
  • Hypothyroidism
  • Male hypogonadism
  • Growth hormone deficiency
  • Hypoparathyroidism

Global Hormone Replacement Therapy Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in Global Hormone Replacement Therapy Market

Available Customizations:

  • With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hormone Replacement Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Estrogen & Progesterone Replacement Therapy, HGH replacement therapy, Thyroid hormone replacement therapy, Testosterone Replacement Therapy, and Parathyroid Hormone replacement)
    • 5.2.2. By Route of Administration (Oral, Parenteral, Transdermal, and Others)
    • 5.2.3. By Disease Type (Menopause, Hypothyroidism, Male hypogonadism, Growth hormone deficiency, and Hypoparathyroidism)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Market Map

6. North America Hormone Replacement Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Route of Administration
    • 6.2.3. By Disease Type
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hormone Replacement Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Route of Administration
        • 6.3.1.2.3. By Disease Type
    • 6.3.2. Mexico Hormone Replacement Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Route of Administration
        • 6.3.2.2.3. By Disease Type
    • 6.3.3. Canada Hormone Replacement Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Route of Administration
        • 6.3.3.2.3. By Disease Type

7. Europe Hormone Replacement Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By Disease Type
    • 7.2.4. By Country
  • 7.3 Europe: Country Analysis
    • 7.3.1. France Hormone Replacement Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Disease Type
    • 7.3.2. Germany Hormone Replacement Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Disease Type
    • 7.3.3. United Kingdom Hormone Replacement Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Disease Type
    • 7.3.4. Italy Hormone Replacement Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Route of Administration
        • 7.3.4.2.3. By Disease Type
    • 7.3.5. Spain Hormone Replacement Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Route of Administration
        • 7.3.5.2.3. By Disease Type

8. Asia-Pacific Hormone Replacement Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By Disease Type
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Hormone Replacement Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Disease Type
    • 8.3.2. India Hormone Replacement Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Disease Type
    • 8.3.3. South Korea Hormone Replacement Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Disease Type
    • 8.3.4. Japan Hormone Replacement Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By Disease Type
    • 8.3.5. Australia Hormone Replacement Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By Disease Type

9. South America Hormone Replacement Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By Disease Type
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Hormone Replacement Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Disease Type
    • 9.3.2. Argentina Hormone Replacement Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Disease Type
    • 9.3.3. Colombia Hormone Replacement Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Disease Type

10. Middle East and Africa Hormone Replacement Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By Disease Type
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Hormone Replacement Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Disease Type
    • 10.3.2. Saudi Arabia Hormone Replacement Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Disease Type
    • 10.3.3. UAE Hormone Replacement Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Disease Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (In case of listed companies)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Bayer AG
    • 15.6.2. Pfizer Inc.
    • 15.6.3. Merck & Co., Inc.
    • 15.6.4. TherapeuticsMD, Inc.
    • 15.6.5. Novo Nordisk A/S
    • 15.6.6. AbbVie Inc.
    • 15.6.7. F. Hoffmann-La Roche Ltd. (Genentech)
    • 15.6.8. Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
    • 15.6.9. ASCEND Therapeutics US, LLC. (Besins Healthcare)
    • 15.6.10. Halozyme Therapeutics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer